[go: up one dir, main page]

DK173091D0 - BIOLOGICAL MATERIALS - Google Patents

BIOLOGICAL MATERIALS

Info

Publication number
DK173091D0
DK173091D0 DK911730A DK173091A DK173091D0 DK 173091 D0 DK173091 D0 DK 173091D0 DK 911730 A DK911730 A DK 911730A DK 173091 A DK173091 A DK 173091A DK 173091 D0 DK173091 D0 DK 173091D0
Authority
DK
Denmark
Prior art keywords
biological materials
biological
materials
Prior art date
Application number
DK911730A
Other languages
Danish (da)
Inventor
Mette Sommerlund
Sven Haahr
Anne Moeller-Larsen
Original Assignee
Schleroseforeningen The Danish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schleroseforeningen The Danish filed Critical Schleroseforeningen The Danish
Priority to DK911730A priority Critical patent/DK173091D0/en
Publication of DK173091D0 publication Critical patent/DK173091D0/en
Priority to AU27709/92A priority patent/AU664049B2/en
Priority to CA002121030A priority patent/CA2121030A1/en
Priority to PCT/DK1992/000299 priority patent/WO1993007259A1/en
Priority to EP92921610A priority patent/EP0609305A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK911730A 1991-10-11 1991-10-11 BIOLOGICAL MATERIALS DK173091D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK911730A DK173091D0 (en) 1991-10-11 1991-10-11 BIOLOGICAL MATERIALS
AU27709/92A AU664049B2 (en) 1991-10-11 1992-10-12 Type C-like human retrovirus linked to multiple sclerosis (MS)
CA002121030A CA2121030A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)
PCT/DK1992/000299 WO1993007259A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)
EP92921610A EP0609305A1 (en) 1991-10-11 1992-10-12 Type c-like human retrovirus linked to multiple sclerosis (ms)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK911730A DK173091D0 (en) 1991-10-11 1991-10-11 BIOLOGICAL MATERIALS

Publications (1)

Publication Number Publication Date
DK173091D0 true DK173091D0 (en) 1991-10-11

Family

ID=8107599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK911730A DK173091D0 (en) 1991-10-11 1991-10-11 BIOLOGICAL MATERIALS

Country Status (5)

Country Link
EP (1) EP0609305A1 (en)
AU (1) AU664049B2 (en)
CA (1) CA2121030A1 (en)
DK (1) DK173091D0 (en)
WO (1) WO1993007259A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2715937A1 (en) * 1994-02-04 1995-08-11 Bio Merieux Two pathogenic or infectious agents associated with multiple sclerosis
FR2727428B1 (en) * 1994-11-24 1997-04-30 Bio Merieux MSRV1 VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS AND ITS NUCLEIC CONSTITUENTS
FR2715938B1 (en) * 1994-02-04 1997-01-10 Bio Merieux Nucleic constituents of the MSRV1 virus, associated with multiple sclerosis.
FR2715936B1 (en) * 1994-02-04 1996-04-19 Bio Merieux MSRV1 virus associated with multiple sclerosis, and its nucleic constituents.
FR2715939B1 (en) * 1994-02-04 1996-08-02 Bio Merieux MSRV2 virus associated with multiple sclerosis, and its nucleic constituents.
FR2728585A1 (en) * 1994-12-23 1996-06-28 Bio Merieux Two pathogenic or infectious agents associated with multiple sclerosis
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
FR2689521B1 (en) * 1992-04-03 1996-07-19 Bio Merieux PROCESS FOR OBTAINING AND MAINTAINING A SUSTAINABLE CELL CULTURE INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS, AND BIOLOGICALS DERIVED FROM SAID CULTURE.
FR2689520B1 (en) * 1992-04-03 1996-07-19 Bio Merieux METHOD AND CULTURE MEDIUM FOR OBTAINING CELLS INFECTED WITH A VIRUS ASSOCIATED WITH MULTIPLE SCLEROSIS.
JP4108118B2 (en) * 1993-03-26 2008-06-25 ジェン−プローブ・インコーポレイテッド Detection of human immunodeficiency virus type 1
AU6793394A (en) * 1993-06-01 1994-12-20 Ortwin Faff Direct and biochemically functional detection process of retrovirus in biological samples
DE4416300C2 (en) * 1993-06-01 1997-04-10 Ortwin Dr Faff Method for the direct and biochemically functional detection of retroviruses in biological samples
AU701451B2 (en) * 1993-10-15 1999-01-28 Eva M. Rakowicz-Szulczynska Detection and treatment of breast and gynecological cancer
WO1995021256A1 (en) * 1994-02-04 1995-08-10 Bio Merieux Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
FR2716198B1 (en) * 1994-02-15 1996-04-19 Bio Merieux Cytotoxic factor as associated with multiple sclerosis, its detection and quantification.
GB9506658D0 (en) * 1995-03-31 1995-05-24 Gatsby Charitable Foundation Plant pathogen resistance genes and uses thereof
US6287865B1 (en) 1995-03-31 2001-09-11 Plant Bioscience Limited Cf-2 plant pathogen resistance genes
FR2737500B1 (en) 1995-08-03 1997-08-29 Bio Merieux VIRAL MATERIAL AND NUCLEOTIDE FRAGMENTS ASSOCIATED WITH MULTIPLE SCLEROSIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS
US6582703B2 (en) 1996-11-26 2003-06-24 Bio Merieux Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting
FR2765588A1 (en) * 1997-07-07 1999-01-08 Bio Merieux RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS ESPECIALLY ASSOCIATED WITH MULTIPLE SCLEROSIS AND / OR RHUMATOID POLYARTHRITIS, FOR DIAGNOSIS, PROPHYLACTICS AND THERAPEUTICS
ES2153807T3 (en) 1997-08-08 2005-06-16 Biomerieux B.V. SEQUENCES OF NUCLEIC ACID THAT CAN BE USED AS PRIMERS AND PROBES IN THE AMPLIFICATION AND DETECTION OF ALL HIV-1 SUBTIPOS.
JP2002511277A (en) * 1998-04-08 2002-04-16 エムエス・リサーチ・アクティーゼルスカブ Diagnosis of multiple sclerosis and other demyelinating diseases
FR2788784A1 (en) * 1999-01-21 2000-07-28 Bio Merieux New nucleic acid from human endogenous retrovirus, useful e.g. for diagnosis of autoimmune disease and complications of pregnancy, contains at least part of the gag gene
ATE421999T1 (en) 1999-07-09 2009-02-15 Gen Probe Inc DETECTION OF HIV-1 BY AMPLIFICATION OF NUCLEIC ACIDS
US9428815B2 (en) * 2007-04-10 2016-08-30 Emory University HIV-1 reverse transcriptase codon deletion and its use in the management and treatment of HIV infections
CN108144745B (en) * 2017-12-20 2020-06-16 天康生物股份有限公司 Separation device and method for reducing endotoxin content of live brucellosis vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
EP0326395A2 (en) * 1988-01-29 1989-08-02 City Of Hope Method of detecting and identifying certain viral sequences
EP0384566A3 (en) * 1989-01-27 1991-11-13 The Wistar Institute Amplification of htlv-1 sequences from multiple sclerosis patients
EP0557388A4 (en) * 1990-11-14 1994-07-06 Univ Company Pty Ltd Diagnosis and treatment of multiple sclerosis

Also Published As

Publication number Publication date
WO1993007259A1 (en) 1993-04-15
AU2770992A (en) 1993-05-03
AU664049B2 (en) 1995-11-02
EP0609305A1 (en) 1994-08-10
CA2121030A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
DK39692D0 (en) BIOLOGICAL MATERIALS
DK173091D0 (en) BIOLOGICAL MATERIALS
FI97863B (en) Brand- and vaermehaerdiga material
FI930259A0 (en) POLYMERT PIEZOELEKTRISKT MATERIAL
DE69228957D1 (en) Blood compatible material
DE69118371D1 (en) ANIMAL REQUIRING MATERIAL
NO923644D0 (en) rOOFING MATERIALS
FI931966A0 (en) ROENTGENKONTRASTMEDELSKOMPOSITIONER INNEHAOLLANDE FILMBILDANDE MATERIAL
DK490388D0 (en) MATERIAL
DE69212780D1 (en) Self-metabolizing functional material
FI915618A0 (en) MATERIALS FOER SKOERDARAGGREGAT.
DK150791D0 (en) BIOLOGICAL MATERIALS
BR9106570A (en) CONSTRUCTION MATERIALS
FI904816A0 (en) MATERIALS FOER PULVERFORMIGT MATERIAL.
DK131489D0 (en) GASTAET MATERIALS
FI931782A0 (en) PLOG
NO920764L (en) RESISTANT MATERIALS
NO891180D0 (en) GASSTETT MATERIALS.
FI931147A0 (en) SUPRALEDAND MATERIAL
FI930245A (en) EKOLOGISK BEHAOLLARE FOER FOERORENANDE MATERIAL
ITBO910422A0 (en) CERAMIC MATERIAL
NO913246D0 (en) MATERIAL.
NO910431D0 (en) MATERIAL.
DK132890D0 (en) PLASTER MATERIALS
ITTO921029A0 (en) PLASTIC MATERIAL SPECIMEN.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)